Oxandrolone 10mg/tab 100 Tabletten by Kim Pharma

Usage

1. Map your annual training calendar before starting: define the intended blast objective (e.g., strength peak, contest prep hardening), set a fixed blast end date, and schedule the cruise phase duration based on target bloodwork recovery windows.
2. Begin the blast phase at the lower end of your target dose range — typically 20 mg/day for men — and confirm tolerance across the first five to seven days before advancing to 30 mg/day if programmed.
3. Administer tablets in two evenly spaced daily doses to distribute anabolic exposure across the day's highest-output activity windows; swallow whole with water and a meal to support gastric tolerance.
4. At the defined blast end point, reduce intake by exactly one 10 mg tablet per day to enter the cruise phase; no further tapering is required given Oxandrolone's rapid plasma clearance of approximately 48 hours post final dose.
5. During the cruise phase, maintain the single daily 10 mg dose consistently; use this window to collect bloodwork (lipid panel, haematocrit, liver enzymes, hormonal baseline) that will inform the timing and dose structure of the next blast.
6. Do not extend a blast phase beyond the planned endpoint on the basis of subjective performance alone — phase discipline is the defining principle of cruise-and-blast methodology, and adherence to pre-set timelines protects long-term biomarker health.

Warnings

Frequently asked questions

What is the cruise and blast method and how does Oxandrolone fit into it?

Cruise and blast is a long-term cycling strategy that alternates high-dose blast phases — designed for peak anabolic output — with lower-dose cruise phases that reduce cumulative physiological burden while maintaining baseline hormonal support. Oxandrolone slots into both phases: at higher doses during the blast for lean-mass and strength emphasis, and at minimal daily doses during the cruise to sustain anabolic tone without adding significant load.

How long should the cruise phase last before switching back to a blast?

Most structured cruise-and-blast programmes run cruise phases for 6–12 weeks, though individual scheduling depends on biomarkers, bloodwork results, and training objectives. The cruise phase ends when key health markers — lipid panel, haematocrit, liver enzymes — have recovered to acceptable baselines. Using Oxandrolone's short plasma clearance window of approximately 48 hours, transition back into a blast phase is pharmacokinetically clean and does not require a washout buffer.

At what point during a blast should I transition down to a cruise dose of Oxandrolone?

The switch from blast to cruise dosing typically occurs when the blast's primary objective — a strength peak, a conditioning block, or a mass phase — has been achieved, or when pre-defined bloodwork thresholds signal it is time to reduce load. With Kim Pharma's 10 mg tablet format, the step-down is a single tablet removed per day, giving users a one-step transition without partial tablet splitting or liquid measuring.

Why does the 10 mg tablet strength matter specifically for cruise and blast programming?

The 10 mg per tablet unit is the lowest commercially uniform Oxandrolone tablet strength available, making it the most versatile format for phase-specific dose adjustment. During a blast, adding 10 mg increments is straightforward; during a cruise, 10 mg per day represents the floor of documented anabolic activity and is achievable without splitting. Higher-strength tablets — 25 mg or 50 mg — require fragmentation to reach cruise-phase targets, introducing dose inaccuracy that the 10 mg format eliminates.

Can Kim Pharma Oxandrolone 10mg tablets be stored for multi-phase use across a full cruise-blast year?

Yes. The 100-tablet pack format supports multi-phase planning: a single pack can cover a 6–8 week blast at 20 mg per day with tablets remaining for a subsequent cruise phase at 10 mg per day. Tablets should be stored in a cool, dry location away from direct light and humidity. Kim Pharma's blister or sealed packaging maintains tablet integrity over the storage period, making advance purchasing for a full annual cycle practical and dose-accurate. (2) angle_used

Manufacturer

Kim Pharma's customer-facing service infrastructure is built around a straightforward principle: athletes running structured blast-and-cruise programmes cannot afford ambiguity at the product level, and the brand's support model reflects this. Batch-specific documentation — including HPLC potency data and LAL endotoxin results — is accessible to end users on request, giving practitioners a verifiable record that connects their specific pack to its production batch rather than relying on generalised quality statements. Kim Pharma's customer support channels are staffed to handle documentation queries directly, without routing users through reseller intermediaries who may not hold batch-level records. This direct documentation access is particularly relevant for long-cycle athletes who purchase multiple packs across a single annual programme and require cross-batch potency consistency to maintain phase-to-phase dose integrity. The brand's responsiveness on authentication queries — including code verification against its batch registry — is designed to resolve concerns at the point of use rather than after a cycle is already underway.